Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations
Cancers · 13.12.2025 · 17 (24) · 3981
DOI: 10.3390/cancers17243981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.12.2025. Verfasst von Seyma Eroglu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary cancer syndrome significantly increasing the risk of colorectal cancer (CRC) and various extracolonic cancers, including endometrial, ovarian, and gastric cancers. LS results from germline pathogenic variants (GPVs) in DNA mismatch repair (MMR) genes, such as MLH1, MSH2, MSH6, and PMS2, leading to microsatellite instability (MSI). This review explores the multifaceted aspects of LS, covering clinical presentation, genetic underpinnings, and emerging therapeutic strategies. The discussion explores the importance of identifying at-risk individuals, facilitating personalized cancer surveillance and prevention strategies. Molecular insights into distinguishing between sporadic and LS-associated cancers are also examined, with a focus on somatic testing methods, including MSI and immunohistochemistry (IHC). The gynecological cancer risks, particularly those related to endometrial and ovarian malignancies, are addressed, underscoring the need for early detection and risk-reducing interventions. Recent advancements in the management of colorectal and other LS-related cancers are highlighted, with particular attention to the growing role of immunotherapy, including immune checkpoint inhibitors, and immunoprevention strategies. With ongoing advances in our understanding of LS, opportunities for earlier detection, more effective prevention, and innovative treatments continue to expand. This narrative review adopts a multidisciplinary approach to provide a comprehensive understanding of LS, from its genetic basis to current clinical and therapeutic practices, with the ultimate goal of improving patient outcomes and enhancing the quality of care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Independent Researcher, Bethesda, MD 20814, USA.
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.
- Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.
- The Defense Health Agency, Falls Church, VA 22042, USA.
ORCID-Profile: Seyma Eroglu, Ilhan Birsenogul, Edwin Gandia, Danielle M Pastor, Juvianee I Estrada-Veras
Zitieren
APA
Eroglu, S., Birsenogul, I., Bowen, A. P., Doyle, J. F., Pupkin, S. E., Villar, J., Tarney, C. M., Gandia, E., Pastor, D. M., & Estrada-Veras, J. I. (2025). Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations. Cancers, 17(24), 3981. https://doi.org/10.3390/cancers17243981
Vancouver
Eroglu S, Birsenogul I, Bowen AP, Doyle JF, Pupkin SE, Villar J, et al. Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations. Cancers. 2025;17(24):3981. doi:10.3390/cancers17243981
BibTeX
@article{Eroglu2025,
author = {Eroglu, Seyma and Birsenogul, Ilhan and Bowen, Alexandra P and Doyle, Joseph F and Pupkin, Stephen E and Villar, Joaquin and Tarney, Christopher M and Gandia, Edwin and Pastor, Danielle M and Estrada-Veras, Juvianee I},
title = {Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations},
journal = {Cancers},
year = {2025},
volume = {17},
number = {24},
pages = {3981},
doi = {10.3390/cancers17243981}
}
EUVIMED